[Development of antitumor immunity in animals treated with carminomycin].
Sensitivity of the mice inoculated with ascitic NK/Ly cells and cured with carminomycin to repeated inoculation with the same tumour was studied. It was found that curing with carminomycin was accompanied by development of resistance to the repeated inoculation. Such resistance might be transferred to intact singeneic mice with a suspension of the cells of the spleen or lymph nodes from unsusceptible donors. The transfer of the thymus cells from the above donors protected the recipients only partially. The spleen cells from intact donors, as well as their lymph node cells did not inhibit the tumour development. The thymus cells of the intact mice induced some suppression, thus probably favouring the active immune response in the recipient. Curing of the NK/Ly-inoculated mice with carminomycin was a more effective method for induction of immunity to the tumour than immunization of mice with NK/Ly cells inactivated by UV irradiation in vitro
D000818:Animals; D002360:Carubicin / Q000276:immunology* / Q000627:therapeutic use; D003630:Daunorubicin / Q000031:analogs & derivatives*; D004353:Drug Evaluation, Preclinical; D007109:Immunity / Q000187:drug effects / Q000528:radiation effects; D007114:Immunization; D007116:Immunization, Passive; D008223:Lymphoma / Q000188:drug therapy / Q000276:immunology*; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000276:immunology; D014466:Ultraviolet Rays
D002360:Carubicin; D003630:Daunorubicin
Razvitie protivoopukholevogo immuniteta u zhivotnykh, lechennykh karminomitsinom.